According to ai_9684xtpa analysis, BIO Protocol has raised $30.2 million through fundraising: two rounds of private placement, a total of 2.3 million US dollars, with a valuation of 35 million US dollars and 69 million US dollars respectively; The three rounds of public offering (i.e. BIO Genesis auction) raised a total of 27.9 million US dollars, and the three rounds were valued at 85 million US dollars/142 million US dollars/219 million US dollars. At present, BIO has launched Bybit and Bitget pre-market trading. According to the pre-market average price of 0.9659 dollars on the two platforms at 12.29 22:00, BIO FDV is about 3.20 billion dollars. Private investors: 13.60% of the total supply; Public investors: 20.00% of the total supply. Costs are as follows: private placement Before the seed round: the cost is about $0.01054, and the current floating profit is 91.62 times. In the seed round: the cost is about $0.02078, and the current floating profit is 46.48 times. public offering · Round 1: The cost is about $0.0256, and the current floating profit is 37.73 times; · Round 2: The cost is about $0.04277, and the current floating profit is 22.58 times; Round 3: The cost is about $0.06596, and the current floating profit is 14.64 times.